Device Trial Radar · NCT06343285
Upper Limb Tremor Reduction in Essential Tremor Patients
Last checked: Nov 19, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
71
Actual
Start
Jan 1, 2024
Primary completion
Jul 3, 2024
Study completion Nov 12, 2024
Sponsor
- Lead sponsor
- Encora, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 2, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to demonstrate the safety, tolerability, and efficacy of the Encora Therapeutics Tremor Mitigation Device in subjects with upper limb tremor caused by Essential Tremor.
Conditions
- Essential Tremor
Interventions
Encora Therapeutics Tremor Reduction DeviceDevice
The proposed therapeutic device uses vibration motors positioned around the wrist that provide on-demand-therapy to suppress resting, postural, or action tremors of the hand.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tolerability (Rate of Subject-Assessed Comfort with Stimulation)Time frame: At the end of the 5-day treatment period in all randomization arms
- Safety (Rate of Adverse Events)Time frame: At the end of the 5-day treatment period in all randomization arms
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Encora Therapeutics
Cambridge, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.